Patient Guide: A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 80 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT02138734
Status: 🟢 Enrolling Now
Condition: Non-muscle Invasive Bladder Cancer
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 80 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Anchorage, Alaska
  • • Little Rock, Arkansas
  • • And 77 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer - Join Clinical Trial NCTNCT02138734

How to Join This Clinical Trial - NCTNCT02138734

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Non-muscle Invasive Bladder Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-muscle Invasive Bladder Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-muscle Invasive Bladder Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT02138734 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 80 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294 - United States

Status: COMPLETED

Clinical Research Site

Anchorage, Alaska 99503 - United States

Status: COMPLETED

Clinical Research Site

Little Rock, Arkansas 72211 - United States

Status: COMPLETED

Clinical Research Site

Irvine, California 92618 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90095 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Sacramento, California 95817 - United States

Status: COMPLETED

Clinical Research Site

San Diego, California - United States

Status: RECRUITING

Clinical Research Site

Sherman Oaks, California 91411 - United States

Status: COMPLETED

Clinical Research Site

Torrance, California 90505 - United States

Status: COMPLETED

Clinical Research Site

Norwich, Connecticut 06360 - United States

Status: COMPLETED

And 70 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Non-muscle Invasive Bladder Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships